$11.30
3.42% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$11.30
+3.15 38.65% 1M
+4.27 60.74% 6M
+5.81 105.83% YTD
+5.29 88.02% 1Y
-49.61 81.45% 3Y
-32.37 74.12% 5Y
-11.73 50.93% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.40 3.42%
ISIN
US45780L1044
Symbol
INGN
Sector

Key metrics

Market capitalization $268.02m
Enterprise Value $168.21m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.51
P/S ratio (TTM) P/S ratio 0.82
P/B ratio (TTM) P/B ratio 1.43
Revenue growth (TTM) Revenue growth -6.48%
Revenue (TTM) Revenue $326.65m
EBIT (operating result TTM) EBIT $-55.23m
Free Cash Flow (TTM) Free Cash Flow $-17.63m
Cash position $121.25m
EPS (TTM) EPS $-3.97
P/E forward negative
P/S forward 0.82
EV/Sales forward 0.51
Short interest 5.71%
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Inogen, Inc. forecast:

1x Buy
25%
2x Hold
50%
1x Sell
25%

Analyst Opinions

4 Analysts have issued a Inogen, Inc. forecast:

Buy
25%
Hold
50%
Sell
25%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
327 327
6% 6%
100%
- Direct Costs 177 177
12% 12%
54%
149 149
2% 2%
46%
- Selling and Administrative Expenses 163 163
15% 15%
50%
- Research and Development Expense 21 21
5% 5%
6%
-35 -35
137% 137%
-11%
- Depreciation and Amortization 20 20
0% 0%
6%
EBIT (Operating Income) EBIT -55 -55
58% 58%
-17%
Net Profit -92 -92
4% 4%
-28%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Neutral
Seeking Alpha
about one month ago
Inogen, Inc. (NASDAQ:INGN ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ryan Peterson - IR Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan James Beer - William Blair Colin Clark - Stifel Michael Matson - Needham & Company Operator Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [...
Positive
InvestorPlace
about 2 months ago
Investing in small-cap stocks can be a gateway to high returns, mainly when these companies exhibit strong growth fundamentals and strategic market positioning. Here, the focus is on three stocks to buy under $10.
Neutral
Business Wire
2 months ago
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Exe...
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 834
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today